Company: G
Filing Date: 2025-11-07
Form Type: 10-Q
Source: 0001398659-25-000109
Chunk: 59

Company: Genpact LTD
Filing Date: 2025-11-07
Form: 10-Q
Item: Part I, Item 1
Chunk 59
---
 rate fluctuations(13,766)(4,087)Closing balance$12,094 $25,241 Accounts receivable were $1,210,700 and $1,306,179, and allowances for credit losses were $12,094 and $25,241, resulting in net accounts receivable balances of $1,198,606 and $1,280,938 as of December 31, 2024 and September 30, 2025, respectively.In addition, deferred billings were $130,253 and $199,818 and allowances for credit losses on deferred billings were $7,320 and $8,294, resulting in net deferred billings balances of $122,933 and $191,524 as of December 31, 2024 and September 30, 2025, respectively.During the three months ended September 30, 2024 and 2025, the Company recorded a charge of $928 and $433, respectively, and for the nine months ended September 30, 2024 and 2025, a charge of $5,344 and $974, respectively, to the income statement on account of credit losses on deferred billings. Deferred billings, net of related allowances for credit losses, are included under “Other assets” in the Company’s consolidated balance sheets as of December 31, 2024 and September 30, 2025.    The Company has a revolving accounts receivable-based facility of $60,000 as of December 31, 2024 and September 30, 2025 permitting it to sell accounts receivable to banks on a non-recourse basis in the ordinary course of business. The aggregate maximum capacity utilized by the Company at any time during the year ended December 31, 2024 and the nine months ended September 30, 2025 was $55,870 and $59,952, respectively. The principal amount outstanding against this facility as of December 31, 2024 and September 30, 2025 was $26,583 and $54,274, respectively. The cost of factoring such accounts receivable during the three and nine months ended September 30, 2024 and 2025 was $589 and $498, respectively, and $2,015 and $1,579, respectively. Gains or losses on the sales are recorded at the time of transfer of the accounts receivable and are included under "interest income (expense), net" in the